Overview

Corneal Uptake of Riboflavin Eye Drops

Status:
Completed
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
The overall objective of this study is to optimise the corneal cross-linking standard protocol in terms of a more economical use of the resource "medical personnel" and in terms of increased patient participation. If it can be shown that the riboflavin necessary for corneal cross-linking does not necessarily have to be applied directly on the cornea (as currently performed by the nurses), but can also be applied in the inferior fornix (as it would be performed by patients in the context of self-application), then it would be conceivable to transfer this task from medical staff to the patients.
Phase:
N/A
Details
Lead Sponsor:
Luzerner Kantonsspital
Treatments:
Ophthalmic Solutions
Riboflavin